Vifor Pharma AG logo

Vifor Pharma AG - Registered Shares

XSWX:VIFN (Switzerland)   Registered Shares
(Delisted) CHF 166.15 (0%) Dec 23
78.66
P/B:
3.29
Market Cap:
CHF 10.78B ($ 11.83B)
Enterprise V:
CHF 10.38B ($ 11.38B)
Volume:
-
Avg Vol (2M):
4.03K

Business Description

Description
Vifor Pharma AG is a specialty drug manufacturing and licensing company. It researches, develops, and produces its pharmaceutical products and markets and distributes them worldwide. Most of its sales are generated in the USA, with Europe also a strong contributor. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
Name Current Vs Industry Vs History
Cash-To-Debt 1.69
Equity-to-Asset 0.68
Debt-to-Equity 0.17
Debt-to-EBITDA 0.91
Interest Coverage 39.56
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 7.89
Distress
Grey
Safe
Beneish M-Score -3.04
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
6-1 Month Momentum % -0.23
12-1 Month Momentum % 5.09

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.91
Quick Ratio 1.56
Cash Ratio 1.01
Days Inventory 198.26
Days Sales Outstanding 87.24
Days Payable 81.91